Anemia Clinical Trial
Official title:
Milking the Umbilical Cord at Term Cesarean Birth: Effect on Hemoglobin Levels in the First 48 Hours of Life
The purpose of this pilot study is to determine if umbilical cord milking at the time of scheduled cesarean section effects the hemoglobin and hematocrit levels of full-term infants as determined by hemoglobin and hematocrit levels at 36-48 hours of life. This study will help to establish the feasibility of umbilical cord milking as an alternative to delayed clamping at the time of planned cesarean section.
New evidence suggests the practice of immediate clamping and cutting of the umbilical cord
at birth may contribute to anemia in infancy. Immediate clamping can deprive a full term
infant of 60 to 100 ml of whole blood representing 30 to 50 mg/kg of iron. The "low tech-low
cost" intervention of delayed cord clamping can reduce anemia in infancy by enhancing
placental-infant transfusion at birth. The risk of maternal bleeding makes a delay in cord
clamping at the time of cesarean section challenging. In the United States (US), immediate
clamping and cutting of the umbilical cord is the usual practice at the time of cesarean
section. Milking of the umbilical cord may offer an alternative to delayed cord clamping for
the prevention of anemia in infancy when time and speed are critical factors at the time of
cesarean section. Although some obstetrical and pediatric providers fear adverse outcomes
from delayed cord clamping or umbilical cord milking such as polycythemia or jaundice, the
most recent clinical trials fail to support these fears.
In spite of iron supplementation and iron fortified formula and food, iron deficiency in
infants and toddlers remains a significant public health problem in the US. Poor iron stores
in the first year of life can lead to iron deficiency which has the potential to cause harm
to the developing brain.
The number of births by cesarean section is on the rise in this country. According to the
latest US birth data reported by the National Center for Health Statistics, the cesarean
section rate is now above 32%, over a 50% increase since 1996. Immediate cord clamping is
routine practice at the time of cesarean section in the US. Consequently over 1.4 million
babies annually will have their umbilical cords cut immediately at the time of birth. This
routine practice interferes in placental transfusion and results in less blood volume and
red blood cells and increases anemia at birth and lowers total body iron stores in the
newborn at six months. The potential effect of immediate cord clamping at cesarean section
is enormous on the public health of infants in this country. However the association between
cord clamping time and infant well-being is not generally recognized by clinicians.
Delaying the clamping and cutting of the cord for just two minutes is known to offer benefit
and can improve the iron stores of term newborns extending into at least the first six
months of life. Although there is benefit for the baby, a two minute delay is not feasible
for the mother at time of cesarean section. However, milking of the umbilical cord at the
time of cesarean section may be a viable alternative to delayed cord clamping and may
prevent anemia and infant iron deficiency. Most of the available literature on umbilical
cord milking was written over 50 years ago. Even so, these studies support the technique as
safe for term infants resulting in higher neonatal hemoglobin and hematocrit levels. One
recent study found cord milking was beneficial and did not cause harm in very low birth
weight preterm infants.
This study will help to establish the feasibility of using umbilical cord milking as an
alternative to delayed cord clamping at the time of cesarean section. Umbilical cord milking
will be examined as a selective intervention to accelerate placental transfusion when
delayed clamping is not ideal. It has the potential to prevent anemia and iron deficiency in
infancy in full-term infants born by cesarean section.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
| Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
| Completed |
NCT03341338 -
Genes-in-Action - Hepcidin Regulation of Iron Supplementation
|
||
| Completed |
NCT00060398 -
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
|
Phase 3 | |
| Recruiting |
NCT05384691 -
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
|
Phase 2 | |
| Not yet recruiting |
NCT06309641 -
Methemoglobinemia Following Intravenous Iron Treatment
|
||
| Completed |
NCT03822884 -
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT02930850 -
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
|
N/A | |
| Completed |
NCT02912494 -
A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
| Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
| Completed |
NCT02912533 -
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
| Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
| Completed |
NCT02603250 -
Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda
|
N/A | |
| Completed |
NCT02176759 -
Iron Absorption From Rice Fortified With Ferric Pyrophosphate
|
N/A | |
| Withdrawn |
NCT01934842 -
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
|
N/A | |
| Completed |
NCT02310113 -
Transfusion and Skeletal Muscle Tissue Oxygenation
|
N/A | |
| Completed |
NCT01922479 -
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
|
Phase 4 | |
| Completed |
NCT01693029 -
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
|
Phase 3 | |
| Terminated |
NCT01535781 -
Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced?
|
N/A | |
| Completed |
NCT01432717 -
Study of ACE-536 in Healthy Postmenopausal Women
|
Phase 1 |